24 May 2013
Keywords: wilex, completes, ph, trial, anticancer, drug, munich
Article | 01 August 2005
Munich, Germany-based, privately-held biopharmaceutical group Wilex AG has successfully completed a Phase I clinical trial of its new, oral,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 August 2005
25 July 2005
23 May 2013
© 2013 thepharmaletter.com